Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas
Virginia Laspidea, Montse Puigdelloses, Sara Labiano, et al.
JCI Insight (2022) Vol. 7, Iss. 7
Open Access | Times Cited: 18

Showing 18 citing articles:

TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory
Iker Ausejo‐Mauleon, Sara Labiano, Daniel de la Nava, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1911-1926.e8
Open Access | Times Cited: 48
Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma
Lauren Arms, Ryan J. Duchatel, Evangeline R. Jackson, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 835-865
Open Access | Times Cited: 6
Immune Microenvironment and Immunotherapies for Diffuse Intrinsic Pontine Glioma
Yujia Chen, Chao Zhao, Shenglun Li, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 602-602
Open Access | Times Cited: 15
The rise of TIM‐3: A promising immune target in diffuse midline gliomas
Iker Ausejo‐Mauleon, Sara Nuin, Marta M. Alonso
Clinical and Translational Medicine (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma
Ming‐Ming Hu, XuLiang Liao, Tao Yi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Therapeutic Strategies to Enhance Tumor Antigenicity: Making the Tumor Detectable by the Immune System
Daniel Meraviglia-Crivelli, Angelina Zheleva, Martin Barainka, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1842-1842
Open Access | Times Cited: 14
Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology
Jessica Foster, Marta M. Alonso, Elias Sayour, et al.
Neoplasia (2023) Vol. 42, pp. 100909-100909
Open Access | Times Cited: 6
The Emerging Field of Viroimmunotherapy for Pediatric Brain Tumors
Marc García-Moure, Virginia Laspidea, Sumit Gupta, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 11, pp. 1981-1993
Closed Access | Times Cited: 1
Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies
Guohao Liu, Yanmei Qiu, Po Zhang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1762-1762
Open Access | Times Cited: 7
Personalizing Oncolytic Immunovirotherapy Approaches
Georgios M. Stergiopoulos, Ianko Iankov, Evanthia Galanis
Molecular Diagnosis & Therapy (2023) Vol. 28, Iss. 2, pp. 153-168
Closed Access | Times Cited: 3
Neurosurgical Clinical Trials for Glioblastoma: Current and Future Directions
Ashish H. Shah, John D. Heiss
Brain Sciences (2022) Vol. 12, Iss. 6, pp. 787-787
Open Access | Times Cited: 5
Locked and loaded: engineering and arming oncolytic adenoviruses to enhance anti-tumor immune responses
Shao‐Chia Lu, Michael A. Barry
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 11, pp. 1359-1378
Open Access | Times Cited: 5
Promises of oncolytic viral therapy for adult and children with brain glioma
Ana Patiño-Garcı́a, Marta M. Alonso, Jaime Gállego Pérez‐Larraya
Current Opinion in Oncology (2023) Vol. 35, Iss. 6, pp. 529-535
Closed Access | Times Cited: 2
Oncolytic virotherapy for the treatment of pediatric brainstem gliomas
Jaime Gállego Pérez‐Larraya, Marc García-Moure, Marta M. Alonso
Revue Neurologique (2023) Vol. 179, Iss. 5, pp. 475-480
Open Access | Times Cited: 1
TIM-3 blockade: immune and targeted therapy in DIPG
Yan Hu, Peishan Hu, Xiaozhong Peng
Trends in Molecular Medicine (2023) Vol. 30, Iss. 2, pp. 110-112
Closed Access | Times Cited: 1
Characterization of immune populations in the tumor microenvironment of diffuse midline glioma orthotopic mouse models by flow cytometry
Iker Ausejo‐Mauleon, Sara Labiano, Marta M. Alonso
STAR Protocols (2023) Vol. 5, Iss. 1, pp. 102803-102803
Open Access | Times Cited: 1
TIM-3 blockade as a therapeutic approach for diffuse intrinsic pontine glioma
Ausejo Iker
(2023)
Open Access
Oncolytic adenovirus Delta-24- RGD engineered to express 4-1BBL or OX40L as therapeutic approach for diffuse intrinsic pontine gliomas
Virginia Laspidea
(2022)
Open Access
Page 1

Scroll to top